Clinical Trials Logo

Varicella Zoster Vaccine clinical trials

View clinical trials related to Varicella Zoster Vaccine.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03493776 Active, not recruiting - Clinical trials for Varicella Zoster Vaccine

Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

Start date: April 15, 2018
Phase: Phase 4
Study type: Interventional

The investigators plan to study the immunogenicity of the vaccine before and after lung transplantation. Patients (at least 50 years old) before and after lung transplantation will be enrolled. The investigators hypothesize that the recombinant varicella-zoster subunit vaccine is able to induce cellular immunogenicity after transplantation.